Device User Fee Proposal To Be Discussed By HIMA Board At Annual Meeting
This article was originally published in The Gray Sheet
Executive Summary
A discussion on device user fees between a top health official in the Office of Management and Budget and the Health Industry Manufacturers Association board of directors suggests stepped-up efforts by the White House to generate support for its budget proposal and a potential willingness on the part of large device firms to reconsider their past opposition to user fees.
You may also be interested in...
Kennedy Opposition Halts Device User Fee, Third-Party Expansion Momentum
House and Senate conferees are likely to include Prescription Drug User Fee Act (PDUFA) reauthorization and medical device reforms in the Public Health Security and Bioterrorism Response Act of 2001 (HR 3448) when they meet to reconcile the measure, as early as the week of April 15
Kennedy Opposition Halts Device User Fee, Third-Party Expansion Momentum
House and Senate conferees are likely to include Prescription Drug User Fee Act (PDUFA) reauthorization and medical device reforms in the Public Health Security and Bioterrorism Response Act of 2001 (HR 3448) when they meet to reconcile the measure, as early as the week of April 15
Device User Fee Discussions Could Resurface During 107th Congress
Medical device user fees could move back into legislative focus during the 107th Congress, Capitol Hill staffers report.